|
|
Volumn 9, Issue 1, 2013, Pages 9-11
|
|
The kronos early estrogen prevention study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CONJUGATED ESTROGEN;
ESTRADIOL;
ESTROGEN;
GESTAGEN;
PLACEBO;
ARTERIAL WALL THICKNESS;
ATHEROSCLEROSIS;
CARDIOVASCULAR RISK;
CHRONIC DISEASE;
CLINICAL DECISION MAKING;
COGNITIVE DEFECT;
CORONARY ARTERY CALCIFICATION;
DOSE RESPONSE;
DRUG MEGADOSE;
EARLY INTERVENTION;
ESTROGEN THERAPY;
HUMAN;
INSULIN RESISTANCE;
MEDICAL RESEARCH;
MENOPAUSAL SYNDROME;
MENOPAUSE;
OUTCOME ASSESSMENT;
PERSONALIZED MEDICINE;
POSTMENOPAUSE OSTEOPOROSIS;
PREVENTIVE HEALTH SERVICE;
QUALITY OF LIFE;
REPRODUCTIVE HEALTH;
REVIEW;
RISK BENEFIT ANALYSIS;
SEXUAL DYSFUNCTION;
WOMEN'S HEALTH;
ADULT;
CARDIOVASCULAR DISEASES;
ESTROGENS;
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
MENOPAUSE;
MIDDLE AGED;
PROGESTERONE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
WOMEN'S HEALTH;
|
|
EID: 84871241145
PISSN: 17455057
EISSN: 17455065
Source Type: Journal
DOI: 10.2217/whe.12.69 Document Type: Review |
|
Times cited : (24)
|
|
References (0)
|
